Comments
Loading...

Elicio Therapeutics

ELTXNASDAQ
Logo brought to you by Benzinga Data
$4.88
-0.20-3.84%
At close: -
$5.70
0.8216.80%
After Hours: Dec 12, 8:00 AM EDT

Elicio Therapeutics (NASDAQ:ELTX) Stock, Earnings Estimates, EPS, And Revenue

Elicio Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 13
EPS
$-1.390
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Elicio Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Elicio Therapeutics (ELTX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-13$-1.39$-0.81-71.6 %
Jun 20242024-08-13$-0.64$-0.9633.3 %
Mar 20242024-05-15$-1.15$-1.214.96 %
Dec 20232024-03-29$-3.77$-0.78-383.3 %

Elicio Therapeutics (ELTX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Elicio Therapeutics (NASDAQ:ELTX) reporting earnings?

A

Elicio Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Elicio Therapeutics (NASDAQ:ELTX)?

A

Elicio Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was $-1.39, which missed the estimate of $-0.81.

Q

What were Elicio Therapeutics’s (NASDAQ:ELTX) revenues?

A

Elicio Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch